Stay updated on Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and a funding-status notice along with Revision: v3.4.1 were removed. These are maintenance changes and do not affect the study content.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about government funding and operating status was added, and the page version updated from v3.4.0 to v3.4.1. There are no changes to the study details, outcomes, or core content presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedA glossary toggle ('Show glossary') was added and the update-label capitalization adjusted. The footer now shows 'Revision: v3.4.0' replacing 'v3.3.4'.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows a minor revision update from v3.3.3 to v3.3.4; this does not affect the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a Locations section with California as a study location and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check85 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. This appears to be an administrative metadata change rather than any modification to study details or content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.